Table 1. Patient characteristics and tumor types in EXACT.
| Gender | n | % |
|---|---|---|
| Male | 35 | 63.6 |
| Female | 20 | 36.4 |
| Age | years | Range |
| 61 | 23-84 | |
| n | % | |
| Alive | 27 | 49.1 |
| Dead | 28 | 50.9 |
| Tumor type | n | % |
| CRC | 7 | 12.3 |
| CCC | 6 | 10.5 |
| Head & neck cancer | 5 | 8.8 |
| Thyroid cancer | 5 | 8.8 |
| Lymphoma | 4 | 7.0 |
| Mesothelioma | 3 | 5.3 |
| CUP | 3 | 5.3 |
| HCC | 2 | 3.5 |
| Esophageal cancer | 2 | 3.5 |
| PEComa (renal) | 2 | 3.5 |
| Ovarian cancer | 2 | 3.5 |
| PDAC | 2 | 3.5 |
| NET | 2 | 3.5 |
| Adrenal cancer | 1 | 1.8 |
| Hepatoid Peritoneum | 1 | 1.8 |
| Vulvar carcinoma | 1 | 1.8 |
| Breast cancer | 1 | 1.8 |
| Prostate cancer | 1 | 1.8 |
| Urothelial cancer | 1 | 1.8 |
| Testicular cancer | 1 | 1.8 |
| Multiple Myeloma | 1 | 1.8 |
| Endometrial cancer | 1 | 1.8 |
| Melanoma | 1 | 1.8 |
| Total | 55 | 100.0% |
CRC: colorectal cancer; CCC: cholangiocarcinoma; CUP: cancer of unknown primary; HCC: hepatocellular carcinoma; PEComa: perivascular epithelioid cell tumor of the kidney; PDAC: pancreatic ductal adenocarcinoma; NET: neuroendocrine tumor.